Telomir Pharmaceuticals

Baltimore, United States

Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function.

$1.0M raised

Apr 2026

Post-IPO Equity

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Starwood Property Trust Bayshore Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Telomir Pharmaceuticals

How much funding has Telomir Pharmaceuticals raised?

Telomir Pharmaceuticals has raised $1.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.

Who are Telomir Pharmaceuticals's investors?

Telomir Pharmaceuticals's investors include Starwood Property Trust, Bayshore Capital.

Where is Telomir Pharmaceuticals headquartered?

Telomir Pharmaceuticals is headquartered in Baltimore, United States.

What does Telomir Pharmaceuticals do?

Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function.

What stage is Telomir Pharmaceuticals at?

Telomir Pharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2026.

MLA

"Telomir Pharmaceuticals — Funding & Investors." VCBacked, April 24, 2026, https://www.vcbacked.co/company/telomir-pharmaceuticals. Accessed July 4, 2026.

APA

VCBacked. (2026). Telomir Pharmaceuticals — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/telomir-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Telomir Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/telomir-pharmaceuticals |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2026.